117 related articles for article (PubMed ID: 36807168)
1. [Gefitinib Monotherapy Afforded Long-Term Survival of an Octogenarian Patient with a Postoperative Recurrence of a Pulmonary Adenocarcinoma-A Case Report].
Kamiyoshihara M; Igai H; Ohsawa F; Numajiri K
Gan To Kagaku Ryoho; 2023 Feb; 50(2):187-189. PubMed ID: 36807168
[TBL] [Abstract][Full Text] [Related]
2. [Alectinib for an Octogenarian Patient with Poor Performance Status and ALK Fusion Gene-Positive Lung Cancer-A Case Report].
Kamiyoshihara M; Igai H; Matsuura N; Yazawa T; Ohsawa F
Gan To Kagaku Ryoho; 2021 Aug; 48(8):1053-1055. PubMed ID: 34404075
[TBL] [Abstract][Full Text] [Related]
3. A case of lung adenocarcinoma with postoperative recurrence of multiple bone metastases that showed a gradual complete response to combined administration of erlotinib and zoledronic acid.
Kosaka T; Yamaki E; Mogi A; Kuwano H
Tumori; 2014; 100(2):e45-8. PubMed ID: 24852875
[TBL] [Abstract][Full Text] [Related]
4. EGFR mutation L747P led to gefitinib resistance and accelerated liver metastases in a Chinese patient with lung adenocarcinoma.
Yu G; Xie X; Sun D; Geng J; Fu F; Zhang L; Wang H
Int J Clin Exp Pathol; 2015; 8(7):8603-6. PubMed ID: 26339441
[TBL] [Abstract][Full Text] [Related]
5. [Multidisciplinary Treatment for Postoperative Recurrent Patients-Report of a Long-Term Survivor].
Kamiyoshihara M; Igai H; Matsuura N; Ohsawa F; Numajiri K
Gan To Kagaku Ryoho; 2022 Oct; 49(10):1117-1119. PubMed ID: 36281606
[TBL] [Abstract][Full Text] [Related]
6. Activity of pemetrexed and high-dose gefitinib in an EGFR-mutated lung adenocarcinoma with brain and leptomeningeal metastasis after response to gefitinib.
Yuan Y; Tan C; Li M; Shen H; Fang X; Hu Y; Ma S
World J Surg Oncol; 2012 Nov; 10():235. PubMed ID: 23134665
[TBL] [Abstract][Full Text] [Related]
7. Surgical resection of advanced non-small cell lung cancer after a response to EGFR-TKI: presentation of two cases and a literature review.
Yamamoto Y; Kodama K; Maniwa T; Takeda M
J Cardiothorac Surg; 2017 Nov; 12(1):98. PubMed ID: 29169381
[TBL] [Abstract][Full Text] [Related]
8. [A case of lung adenocarcinoma with postoperative recurrence maintaining complete remission by treatment with gefitinib].
Morio A; Ninomiya H; Sunada K
Gan To Kagaku Ryoho; 2011 Feb; 38(2):279-81. PubMed ID: 21368495
[TBL] [Abstract][Full Text] [Related]
9. [A case of lung adenocarcinoma wtih exon19 and T790M mutations in EGFR having good response to erlotinib after gefitinib treatment failure].
Tanaka H; Okamoto T; Shinyama M; Matsumura S; Fujii T
Gan To Kagaku Ryoho; 2013 Aug; 40(8):1067-9. PubMed ID: 23986053
[TBL] [Abstract][Full Text] [Related]
10. Long-term complete response to gefitinib after treatment termination in a patient with recurrent post-operative
Watanabe K; Haratake N; Takenaka T; Nagano T; Oku Y; Kosai K; Ono Y; Kohno M; Oda Y
Transl Cancer Res; 2021 Nov; 10(11):5010-5013. PubMed ID: 35116352
[TBL] [Abstract][Full Text] [Related]
11. Somatic mutations in epidermal growth factor receptor underlying complete responsiveness to gefitinib in a Taiwanese female patient with metastatic adenocarcinoma of lung.
Yeh KH; Yeh SH; Wan JP; Shen YC; Cheng AL
Anticancer Drugs; 2005 Aug; 16(7):739-42. PubMed ID: 16027522
[TBL] [Abstract][Full Text] [Related]
12. A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations.
Kim DW; Lee SH; Lee JS; Lee MA; Kang JH; Kim SY; Shin SW; Kim HK; Heo DS
Lung Cancer; 2011 Jan; 71(1):65-9. PubMed ID: 20430469
[TBL] [Abstract][Full Text] [Related]
13. [An octogenarian case of postoperative recurrent lung cancer responding to treatments with radiation plus gefitinib].
Hanaoka T; Sone S; Yamaguchi S; Okada M; Hayano T
Gan To Kagaku Ryoho; 2007 Oct; 34(10):1701-3. PubMed ID: 17940395
[TBL] [Abstract][Full Text] [Related]
14. [A case of adenocarcinoma of the lung with a pulmonary thromboembolism which improved with gefitinib].
Yanagitani N; Horiike A; Kudo K; Ohyanagi F; Nishio M; Horai T
Nihon Kokyuki Gakkai Zasshi; 2011 Apr; 49(4):282-6. PubMed ID: 21591457
[TBL] [Abstract][Full Text] [Related]
15. [Successful Treatment of a Mechanically Ventilated Patient with an Oncological Emergency Caused by Recurrence of Pulmonary Adenocarcinoma].
Kamiyoshihara M; Yoshikawa R; Igai H; Matsuura N; Ohsawa F; Yazawa T
Gan To Kagaku Ryoho; 2019 Dec; 46(12):1895-1897. PubMed ID: 31879411
[TBL] [Abstract][Full Text] [Related]
16. Down-staging of EGFR mutation-positive advanced lung carcinoma with gefitinib followed by surgical intervention: follow-up of two cases.
Levchenko EV; Moiseyenko VM; Matsko DE; Iyevleva AG; Ivantsov AO; Yargnian SM; Anisimov VV; Semionov II; Imyanitov EN
Onkologie; 2009 Nov; 32(11):674-7. PubMed ID: 19887873
[TBL] [Abstract][Full Text] [Related]
17. Gefitinib treatment in patients with postoperative recurrent non-small-cell lung cancer harboring epidermal growth factor receptor gene mutations.
Yokoyama Y; Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Date H
Int J Clin Oncol; 2015 Dec; 20(6):1122-9. PubMed ID: 25953679
[TBL] [Abstract][Full Text] [Related]
18. LUX-Lung 4: a phase II trial of afatinib in patients with advanced non-small-cell lung cancer who progressed during prior treatment with erlotinib, gefitinib, or both.
Katakami N; Atagi S; Goto K; Hida T; Horai T; Inoue A; Ichinose Y; Koboyashi K; Takeda K; Kiura K; Nishio K; Seki Y; Ebisawa R; Shahidi M; Yamamoto N
J Clin Oncol; 2013 Sep; 31(27):3335-41. PubMed ID: 23816963
[TBL] [Abstract][Full Text] [Related]
19. Pathological complete response to gefitinib in a 10-year-old boy with EGFR-negative pulmonary mucoepidermoid carcinoma: a case report and literature review.
Li S; Zhang Z; Tang H; He Z; Gao Y; Ma W; Chang Y; Wei B; Ma J; Liu K; Ma Z; Wang Q
Clin Respir J; 2017 May; 11(3):346-351. PubMed ID: 26148572
[TBL] [Abstract][Full Text] [Related]
20. [Efficacy of low-dose erlotinib against gefitinib-induced hepatotoxicity in a patient with lung adenocarcinoma harboring EGFR mutations].
Kitade H; Yamada T; Igarashi S; Hokkoku K; Mori M; Shintaku K; Sagawa M; Nakai M; Yano S
Gan To Kagaku Ryoho; 2013 Jan; 40(1):79-81. PubMed ID: 23306923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
